{"id":228767,"date":"2026-09-03T10:42:04","date_gmt":"2026-09-03T05:12:04","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=228767"},"modified":"2026-09-03T10:42:06","modified_gmt":"2026-09-03T05:12:06","slug":"kims-hospitals-share-price-buy-hold-or-sell","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/kims-hospitals-share-price-buy-hold-or-sell\/","title":{"rendered":"Krishna Institute of Medical Sciences: Should You Buy, Hold, or Sell Right Now?"},"content":{"rendered":"
<\/div>\n

KIMS share price Rs 753.65 (NSE), roughly flat today. 52-week range Rs 575.80 to Rs 858. Q1 FY27 revenue up 36.1% YoY, but profit fell 56% to Rs 37.4 crore.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Krishna Institute of Medical Sciences (KIMS) share price is trading around Rs 754, roughly 12 percent below its 52-week high of Rs 858 and well above its 52-week low of Rs 575.80. Q1 FY27 revenue grew a strong 36.1 percent year on year to Rs 1,195.9 crore, but net profit fell sharply, down 56 percent, to Rs 37.4 crore from Rs 85 crore a year earlier, a combination that stands out given the stock’s rich trailing valuation. The stock trades at 162.7 times earnings, a significant premium to the hospital sector average near 68 times. This sharp divergence between strong revenue growth and a steep profit decline is a genuine valuation concern investors should weigh carefully, likely reflecting costs from the company’s ongoing hospital network expansion.<\/p>\n<\/div>\n

Krishna Institute of Medical Sciences<\/a> share price has pulled back from its 52-week high of Rs 858, and KIMS share price now trades near Rs 754 on the NSE, well above its 52-week low of Rs 575.80. With revenue growing strongly but profit falling sharply in Q1 FY27, this article looks carefully at whether KIMS is a stock to buy given its expansion story, a hold, or a sell given the very rich valuation against declining profit.<\/p>\n

This KIMS stock analysis walks through the Q1 FY27 numbers, the likely drivers behind the profit decline, valuation against the hospital sector, shareholding pattern and the technical setup, using figures sourced from company disclosures and public filings. Given the scale of the profit decline relative to the stock’s valuation, this article aims to present the numbers with particular care.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n